EXPERIENCE OF USING THE NON­SELECTIVE ENDOTHELIN RECEPTOR ANTAGONIST MACITENTAN IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION

Aim. To present the results of treatment with macitentan of patients included in the clinical trial SERAPHIN in Almazov National Medical Research Centre and define target therapy of pulmonary arterial hypertension (PAH) in real clinical practice.Material and methods. The article presents the results...

Popoln opis

Bibliografske podrobnosti

Principais autores:	M. A. Simakova, N. S. Goncharova, E. V. Karelkina, O. M. Moiseeva
Format:	Artigo
Jezik:	Russo
Izdano:	«SILICEA-POLIGRAF» LLC 2018-04-01
Serija:	Кардиоваскулярная терапия и профилактика
Teme:	pulmonary arterial hypertension endothelin receptor antagonists macitentan seraphin
Online dostop:	https://cardiovascular.elpub.ru/jour/article/view/802
Oznake:	Označite Brez oznak, prvi označite!